Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Maintenance Trial-MedSci.cn

Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Maintenance Trial

Ravandi, F; Pocock, C; Selleslag, D; Montesinos, P; Sayar, H; Musso, M; Alvarez, AF; Safah, H; Tse, W; Sohn, SK; Hiwase, DK; Chevassut, T; Pierdomenico, F; La Torre, I; Skikne, B; Kumar, K; Dong, Q; Beach, CL; Dombret, H

BLOOD, 2020; 136 ():

科室
- - 订阅+
  - 更多科室
工具
服务